Market Cap (In USD)
181.11 Million
Revenue (In USD)
62.37 Million
Net Income (In USD)
-78.98 Million
Avg. Volume
79.4 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.7-7.37
- PE
- -2.85
- EPS
- -0.95
- Beta Value
- 1.032
- ISIN
- CH1125843347
- CUSIP
- H82027105
- CIK
- 1840706
- Shares
- 66831100.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Dr. Jurgi Camblong M.B.A., Ph.D.
- Employee Count
- -
- Website
- https://www.sophiagenetics.com
- Ipo Date
- 2021-07-23
- Details
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
More Stocks
-
1196
-
CARVCarver Bancorp, Inc.
CARV
-
CHD
-
RCELAVITA Medical, Inc.
RCEL
-
MDCLFMedinCell S.A.
MDCLF
-
BLT
-
PTBRY
-
JKON